1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

Meso Foundation announces five new members to its board of directors

board of directors

The Mesothelioma Applied Research Foundation is pleased to announce the addition of five new members to the organization’s board of directors

“The addition of these talented members to our governing board complements the board’s expertise and experiences,” said Mary Hesdorffer, nurse practitioner and executive director of the Mesothelioma Applied Research Foundation. “I look forward to working with them to promote the mission of this Foundation and serving the mesothelioma community.” 

The board assumes responsibility for ensuring the Foundation’s long-term financial stability and integrity and – through consensus and majority vote with the other members – for governing the Foundation and setting its strategic direction and broad policy directives.  

These new members join the following directors: Marjorie G. Zauderer, MD, Memorial Sloan Kettering Cancer Center, board chair; Keith Cengel, MD, PhD, University of Pennsylvania; Patrick Forde, MD, Johns Hopkins University; Jason Foster, MD, University of Nebraska; Aaron Mansfield, MD, Mayo Clinic; R. Taylor Ripley, MD, Baylor University; Rose Buerkley, MSN, RN, University of Chicago; Boris Sepesi, MD, MD Anderson Cancer Center; Daniel Sterman, MD, NYU Langone; James Stevenson, MD, Cleveland Clinic; Antoinette Wozniak, MD, University of Pittsburgh; and Bill Ziegler. 

The Mesothelioma Applied Research Foundation is the only 501(c)(3) nonprofit organization working to eradicate mesothelioma and end this national tragedy. Its programs include the funding of promising and peer-reviewed research, education, support and advocacy. The organization strives to bring together thought leaders in the field to identify the most direct path to a cure. 

Also...

In Other News

Clinical Trials

Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different

Read More »

Peritoneal Surgery/HIPEC

Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC).  This session

Read More »

Share:

Facebook
Twitter
LinkedIn